Drug Copay and Hospitalizations in Elderly Patients with Type 2 Diabetes
| العنوان: | Drug Copay and Hospitalizations in Elderly Patients with Type 2 Diabetes |
|---|---|
| المؤلفون: | Liou Xu, Gary A. Puckrein, Yuexin Tang, Bruce Stuart, Swapnil Rajpathak, Manjiri Pawaskar |
| المصدر: | Diabetes. 67 |
| بيانات النشر: | American Diabetes Association, 2018. |
| سنة النشر: | 2018 |
| مصطلحات موضوعية: | Drug, medicine.medical_specialty, education.field_of_study, business.industry, Endocrinology, Diabetes and Metabolism, media_common.quotation_subject, Population, Medication adherence, Type 2 diabetes, medicine.disease, symbols.namesake, Spouse, Family medicine, Baseline characteristics, Health care, Internal Medicine, medicine, symbols, Poisson regression, business, education, media_common |
| الوصف: | Prior studies have shown that higher drug copay may be associated with a lower medication adherence and higher healthcare resource utilization in type 2 diabetes (T2D) patients but mostly in younger commercially insured population. Hence the current study examined this association in elderly T2D patients. This retrospective database study using Medicare claims database included T2D patients on branded non-insulin anti-hyperglycemic agent (AHA) monotherapy during index period (1/1/2013-2/28/2013). Drug copay was calculated for a 30-day supply of the index AHA. Hospitalization was assessed during 10-month follow-up period. Poisson regression model was used to control for baseline characteristics to evaluate the association between copay and hospitalization. A total of 28,656 T2D elderly patients met the inclusion criteria (mean age 78 years, 53% female, and 90% white). Mean branded drug copay was of $40. Higher drug copay was associated with increase in the risk of hospitalization [(e.g., Compared to patients with Disclosure L. Xu: None. M. Pawaskar: Employee; Self; Merck & Co., Inc. Y. Tang: Employee; Self; Merck & Co., Inc.. Stock/Shareholder; Self; Merck & Co., Inc.. Employee; Spouse/Partner; GlaxoSmithKline plc.. Stock/Shareholder; Spouse/Partner; GlaxoSmithKline plc.. G. Puckrein: None. S. Rajpathak: Employee; Self; Merck & Co., Inc. B.C. Stuart: Consultant; Self; Merck Sharp & Dohme Corp., Novartis Pharmaceuticals Corporation. |
| تدمد: | 1939-327X 0012-1797 |
| DOI: | 10.2337/db18-1259-p |
| URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_________::b48ff5e3665b89fab1b652c468f47d4f https://doi.org/10.2337/db18-1259-p |
| Rights: | CLOSED |
| رقم الانضمام: | edsair.doi...........b48ff5e3665b89fab1b652c468f47d4f |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 1939327X 00121797 |
|---|---|
| DOI: | 10.2337/db18-1259-p |